Overview

Safety and Efficacy Study of Citalopram and Lithium for the Treatment of Depressive Mood Disorder Symptoms

Status:
Completed
Trial end date:
2011-01-01
Target enrollment:
Participant gender:
Summary
The investigators hypothesize that patients receiving citalopram in combination with lithium will have a greater reduction in depressive symptoms than patients receiving citalopram in combination with placebo.
Phase:
Phase 2
Details
Lead Sponsor:
Columbia Northwest Pharmaceuticals
Treatments:
Citalopram
Dexetimide
Lithium Carbonate